<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"><channel><title><![CDATA[Aqemia 보도자료 - 뉴스와이어]]></title><link>https://www.newswire.co.kr/?md=A10&amp;act=article&amp;no=51529></link><description><![CDATA[Aqemia 보도자료 - 뉴스와이어 RSS 서비스]]></description><lastBuildDate>Mon, 20 Jul 2026 08:32:57 +0900</lastBuildDate><copyright>Copyright (c) 2004~2026 Korea Newswire All rights reserved</copyright><image><url><![CDATA[https://file.newswire.co.kr/data/upfile/company_img/2026/07/12_31017998_20260719134944_9256413344.jpg]]></url></image><language>ko-KR</language><item><title><![CDATA[Aqemia and Sanofi Expand Their Research Collaboration]]></title><link>https://www.newswire.co.kr/newsRead.php?no=1038850</link><description><![CDATA[PARIS & LONDON--(Business Wire/Korea Newswire)--Aqemia, the drug invention company combining generative AI and quantum-inspired physics to invent small molecule drugs, today announced the expansion of its multi-year research collaboration with the global pharmaceutical company, Sanofi. The expansion is marked by the nomination of a new therapeutic target and an additional payment.  The collab...]]></description><pubDate>Sun, 19 Jul 2026 13:51:47 +0900</pubDate></item></channel></rss>